Effects of digoxin and digitoxin on circadian blood pressure profile in healthy volunteers

被引:0
|
作者
Grossmann, M
Jamieson, MJ
Kirch, W
机构
[1] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, D-01307 Dresden, Germany
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
关键词
ABPM; blood pressure; digitoxin; digoxin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The aim of the study was to investigate the potential effects of chronic digoxin or digitoxin treatment on circadian blood pressure profile in normotensive subjects. Methods In two randomized double-blind, placebo-controlled cross-over protocols, 22 healthy normotensive subjects were enrolled, 12 subjects in either study. After adequate loading doses, digoxin 0.25 mg twice daily or digitoxin 0.1 mg daily was given for a total of 10 days. Automatic 24-h ambulatory blood pressure measurements were carried out at days 4 and 10 of either glycoside or placebo. Results Digoxin treatment significantly decreased heart rate (HR) and diastolic blood pressure (DBP) during the overnight sleeping phase of day 10 compared with placebo (HR, 4 beats min(-1); DBP, 8 mmHg; P < 0.05). Digitoxin treatment significantly decreased heart rate and diastolic blood pressure during the overnight sleeping phase of day 4 (HR, 8 beats min(-1); DBP, 7 mmHg) and day 10 (HR, 7 beats min(-1); DBP, 5 mmHg) compared with placebo (P < 0.05). Neither digoxin nor digitoxin significantly affected systolic blood pressure. Conclusions Both digoxin and digitoxin, within therapeutic steady-state plasma concentrations, reduce diastolic blood pressure and heart rate during overnight sleep, presumably because of increased parasympathetic activity or decreased sympathetic activity.
引用
收藏
页码:701 / 706
页数:6
相关论文
共 50 条
  • [1] Nocturia and circadian blood pressure profile in healthy elderly male volunteers
    Graugaard-Jensen, Charlotte
    Rittig, Soren
    Djurhuus, Jens Christian
    JOURNAL OF UROLOGY, 2006, 176 (03) : 1034 - 1039
  • [2] Effect of digoxin on circadian blood pressure values in patients with congestive heart failure
    Kirch, C
    Grossmann, M
    Fischer, S
    Neumeister, V
    Kirch, W
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (04) : 285 - 289
  • [3] The Effect of Maraviroc on the Pharmacokinetics of Digoxin in Healthy Volunteers
    Vourvahis, Manoli
    Fang, Juanzhi
    Choo, Heng Wee
    Heera, Jayvant
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (03): : 202 - 206
  • [4] Circadian blood pressure variability in healthy and complicated pregnancies
    Ayala, DE
    Hermida, RC
    Mojon, A
    Fernandez, JR
    Iglesias, M
    HYPERTENSION, 1997, 30 (03) : 603 - 610
  • [5] Effects of a nitrate-rich meal on arterial stiffness and blood pressure in healthy volunteers
    Liu, Alex H.
    Bondonno, Catherine P.
    Croft, Kevin D.
    Puddey, Ian B.
    Woodman, Richard J.
    Rich, Lisa
    Ward, Natalie C.
    Vita, Joseph A.
    Hodgson, Jonathan M.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2013, 35 : 123 - 130
  • [6] Effects of Multiple Doses of Ambrisentan on the Pharmacokinetics of a Single Dose of Digoxin in Healthy Volunteers
    Richards, Duncan B.
    Spence, Rebecca
    Mandagere, Arun
    Henderson, Linda S.
    Magee, Mindy H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01) : 102 - 106
  • [7] Effects of cardiac glycosides on 24-h ambulatory blood pressure in healthy volunteers and patients with heart failure
    Grossmann, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 : 26 - 30
  • [8] A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers
    Teng, Renli
    Butler, Kathleen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (10) : 1801 - 1808
  • [9] A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers
    Renli Teng
    Kathleen Butler
    European Journal of Clinical Pharmacology, 2013, 69 : 1801 - 1808
  • [10] Absence of Interaction of Fondaparinux Sodium with Digoxin in Healthy Volunteers
    Timothy Mant
    Philippe Fournié
    Céline Ollier
    François Donat
    José Necciari
    Clinical Pharmacokinetics, 2002, 41 : 39 - 45